Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Total glucosides of paeony for prevention of acute gout flares
ChiCTR2600117317Phase 4Not yet recruiting
- Sponsor
- Huashan Hospital
- Start
- Jan 2026
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in gout comparing total glucosides of paeony with Control: placebo (2 arms). Primary endpoint: Gout flare occurrence. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
total glucosides of paeony
03
Conditions
gout
Beyond the preview
Go deeper on ChiCTR2600117317.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600117317.